Cargando…
Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms
Over 75 kinase inhibitors (KIs) have been approved for the treatment of various cancers. KIs are orally administrated but mostly lack pediatric age-appropriate dosage forms or instructions for dose manipulation. This is highly problematic for clinical practice in pediatric oncology, as flexible oral...
Autores principales: | Bernsen, Emma C., Hogenes, Valery J., Nuijen, Bastiaan, Hanff, Lidwien M., Huitema, Alwin D. R., Diekstra, Meta H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782008/ https://www.ncbi.nlm.nih.gov/pubmed/36559327 http://dx.doi.org/10.3390/pharmaceutics14122834 |
Ejemplares similares
-
Availability of age-appropriate paediatric formulations in the Netherlands: the need in daily clinical practice remains
por: van der Vossen, Anna, et al.
Publicado: (2021) -
Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology
por: Bernsen, Emma C., et al.
Publicado: (2020) -
Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice
por: Simeoli, Raffaele, et al.
Publicado: (2022) -
Development of a population pharmacokinetic/pharmacodynamic model for various oral paclitaxel formulations co-administered with ritonavir and thrombospondin-1 based on data from early phase clinical studies
por: van Eijk, Maarten, et al.
Publicado: (2022) -
Formulation Challenges and Strategies to Develop Pediatric Dosage Forms
por: Malkawi, Wedad A., et al.
Publicado: (2022)